Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression

BACKGROUND: Clinical decision for primary treatment for prostate cancer is dictated by variables with insufficient specificity. Early detection of prostate cancer likely to develop rapid recurrence could support neo-adjuvant therapeutics and adjuvant options prior to frank biochemical recurrence. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Stabler, Sally, Koyama, Tatsuki, Zhao, Zhiguo, Martinez-Ferrer, Magaly, Allen, Robert H., Luka, Zigmund, Loukachevitch, Lioudmila V., Clark, Peter E., Wagner, Conrad, Bhowmick, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154200/
https://www.ncbi.nlm.nih.gov/pubmed/21853037
http://dx.doi.org/10.1371/journal.pone.0022486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154200/
https://www.ncbi.nlm.nih.gov/pubmed/21853037
http://dx.doi.org/10.1371/journal.pone.0022486

Ejemplares similares